Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-187804
Filing Date
2023-07-17
Accepted
2023-07-17 09:33:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 42680
2 GRAPHIC g483652g0717054532773.jpg GRAPHIC 2687
  Complete submission text file 0001193125-23-187804.txt   47457
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations